Rekah Pharmaceutical Prod Ltd. Logo

Rekah Pharmaceutical Prod Ltd.

A full-service generic pharma manufacturer of drugs, devices, and supplements for global markets.

REKA | TA

Overview

Corporate Details

ISIN(s):
IL0010810096
LEI:
Country:
Israel
Address:
Hamelaha 30, 5881904 Holon
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Rekah Pharmaceutical Prod Ltd. is a generic pharmaceuticals manufacturer with over 70 years of industry experience. The company is active across the entire value chain, from research and development to production, marketing, sales, distribution, import, and export. Its portfolio features over 400 registered products, including generic prescription (Rx) and over-the-counter (OTC) drugs, medical devices, dermo-cosmetics, vitamins, and nutritional supplements. Rekah has in-depth expertise in specific therapeutic categories, specializing in the manufacturing of steroidal tablets, antibiotics, and ophthalmic products. The company focuses on expanding its international footprint through strategic collaborations, co-development partnerships, and licensing agreements.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Rekah Pharmaceutical Prod Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Rekah Pharmaceutical Prod Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Rekah Pharmaceutical Prod Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Global manufacturer of carbapenem antibiotic APIs for regulated markets.
South Korea 106190
HIKMA Pharmaceuticals PLC Logo
Develops & markets affordable generic & specialty medicines for markets in NA, MENA, & Europe.
United Kingdom HIK
HISAMITSU PHARMACEUTICAL CO.,INC. Logo
A global leader in transdermal drug delivery systems for OTC and prescription pain relief.
Japan 4530
HLB Genex, Inc. Logo
Develops custom enzymes & microbiome solutions for diagnostics, nutrition, and cosmetic markets.
South Korea 187420
HLB INC. Logo
A diversified group in pharma, shipbuilding, life sciences, and professional advisory services.
South Korea 028300
HLB Life Science CO.,LTD. Logo
Develops anti-cancer drugs and distributes IVD medical devices and lab supplies internationally.
South Korea 067630
HLB PANAGENE Co., LTD. Logo
A global leader in PNA technology for cancer diagnostics and precision medicine.
South Korea 046210
HLB Pep Co., Ltd. Logo
Develops and produces GMP peptides, APIs, and custom synthesis for the biopharma industry.
South Korea 196300
HLB PHARMACEUTICAL CO., LTD. Logo
Researches cancer drugs and offers pharmaceutical CMO and manufacturing services.
South Korea 047920
HLB SCIENCE Inc. Logo
Develops innovative therapeutics and diagnostics for infectious and neurodegenerative diseases.
South Korea 343090

Talk to a Data Expert

Have a question? We'll get back to you promptly.